188 related articles for article (PubMed ID: 17026494)
1. The metabolic syndrome in type 2 diabetes: When does it matter?
Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
[TBL] [Abstract][Full Text] [Related]
3. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
Athyros VG; Liberopoulos EN; Mikhailidis DP; Papageorgiou AA; Ganotakis ES; Tziomalos K; Kakafika AI; Karagiannis A; Lambropoulos S; Elisaf M
Angiology; 2007 Dec-2008 Jan; 58(6):689-97. PubMed ID: 18216378
[TBL] [Abstract][Full Text] [Related]
4. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus.
Tsai JC; Sheu SH; Chiu HC; Chung FM; Chang DM; Chen MP; Shin SJ; Lee YJ
Diabetes Metab Res Rev; 2007 Feb; 23(2):111-8. PubMed ID: 16703635
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for stroke in Type 2 diabetic patients in Taiwan: a cross-sectional survey of a national sample by telephone interview.
Tseng CH; Chong CK; Sheu JJ; Wu TH; Tseng CP
Diabet Med; 2005 Apr; 22(4):477-82. PubMed ID: 15787676
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
Song SH; Hardisty CA
QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
Lim HS; Lip GY; Beevers DG; Blann AD
Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
[TBL] [Abstract][Full Text] [Related]
9. Nutritional risk and metabolic syndrome in Korean type 2 diabetes mellitus.
Kim WY; Kim JE; Choi YJ; Huh KB
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():47-51. PubMed ID: 18296299
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome in Japanese type 2 diabetic patients and its significance for chronic vascular complications.
Shimajiri Y; Tsunoda K; Furuta M; Kadoya Y; Yamada S; Nanjo K; Sanke T
Diabetes Res Clin Pract; 2008 Feb; 79(2):310-7. PubMed ID: 17933413
[TBL] [Abstract][Full Text] [Related]
11. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus.
Gazzaruso C; Solerte SB; De Amici E; Mancini M; Pujia A; Fratino P; Giustina A; Garzaniti A
Am J Cardiol; 2006 Jan; 97(2):236-9. PubMed ID: 16442369
[TBL] [Abstract][Full Text] [Related]
12. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
13. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
Ovbiagele B; Saver JL; Lynn MJ; Chimowitz M;
Neurology; 2006 May; 66(9):1344-9. PubMed ID: 16682665
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
[TBL] [Abstract][Full Text] [Related]
15. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
[TBL] [Abstract][Full Text] [Related]
16. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
Onat A; Hergenç G; Can G; Küçükdurmaz Z
Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
Song SH; Hardisty CA
QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
[TBL] [Abstract][Full Text] [Related]
18. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).
Mohan V; Sandeep S; Deepa M; Gokulakrishnan K; Datta M; Deepa R
Diabetes Obes Metab; 2007 May; 9(3):337-43. PubMed ID: 17391160
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
Wassink AM; van der Graaf Y; Olijhoek JK; Visseren FL;
Eur Heart J; 2008 Jan; 29(2):213-23. PubMed ID: 18199567
[TBL] [Abstract][Full Text] [Related]
20. Using structural equation model to illustrate the relationship between metabolic risk factors and cardiovascular complications in Taiwan.
Lin JW; Hwang JJ; Dai DF; Tseng YZ
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):633-9. PubMed ID: 16874156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
